BioNTech
BNTX
BNTX
251 hedge funds and large institutions have $4.01B invested in BioNTech in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 71 increasing their positions, 76 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
1% less call options, than puts
Call options by funds: $230M | Put options by funds: $232M
1% less capital invested
Capital invested by funds: $4.05B → $4.01B (-$39.4M)
7% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 76
Holders
251
Holding in Top 10
4
Calls
$230M
Puts
$232M
Top Buyers
| 1 | +$127M | |
| 2 | +$43.9M | |
| 3 | +$37.5M | |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$27.6M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$22.1M |
Top Sellers
| 1 | -$143M | |
| 2 | -$48M | |
| 3 | -$43.7M | |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
-$22.6M |
| 5 |
SM
Senvest Management
New York
|
-$18.8M |